Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126764801 | 12676480 | 1 | I | 2016 | 20160809 | 20160823 | 20160823 | PER | US-GLAXOSMITHKLINE-US2016GSK115859 | GLAXOSMITHKLINE | 0.00 | F | Y | 0.00000 | 20160823 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126764801 | 12676480 | 1 | PS | LAMICTAL | LAMOTRIGINE | 1 | UNK UNK, U | UNKNOWN | 20241 | ||||||||||
| 126764801 | 12676480 | 2 | SS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | 2 IN 1 ONCE | UNKNOWN | 0 | SOLUTION FOR INJECTION | ||||||||
| 126764801 | 12676480 | 3 | SS | TRINTELLIX | VORTIOXETINE HYDROBROMIDE | 1 | UNK UNK, U | UNKNOWN | 0 | ||||||||||
| 126764801 | 12676480 | 4 | SS | LEXAPRO | ESCITALOPRAM OXALATE | 1 | UNK UNK, U | UNKNOWN | 0 | ||||||||||
| 126764801 | 12676480 | 5 | SS | ZYPREXA | OLANZAPINE | 1 | UNK UNK, U | UNKNOWN | 0 | ||||||||||
| 126764801 | 12676480 | 6 | C | ATIVAN | LORAZEPAM | 1 | UNK UNK, U | U | UNKNOWN | 0 | |||||||||
| 126764801 | 12676480 | 7 | C | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | UNK UNK, U | U | UNKNOWN | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126764801 | 12676480 | 1 | Bipolar disorder |
| 126764801 | 12676480 | 2 | Psoriasis |
| 126764801 | 12676480 | 3 | Depression |
| 126764801 | 12676480 | 4 | Product used for unknown indication |
| 126764801 | 12676480 | 5 | Bipolar disorder |
| 126764801 | 12676480 | 6 | Anxiety |
| 126764801 | 12676480 | 7 | Gastrooesophageal reflux disease |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126764801 | 12676480 | Drug interaction | |
| 126764801 | 12676480 | Nausea | |
| 126764801 | 12676480 | Respiratory tract congestion | |
| 126764801 | 12676480 | Throat irritation | |
| 126764801 | 12676480 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126764801 | 12676480 | 2 | 201602 | 0 |